Pioneers in Neuroscience

The Alzheimer’s Puzzle

Working to solve the Alzheimer’s disease problem means following the science and learning from those who came before us, listening to those living with the disease and understanding the impact of Alzheimer’s on society.

These interconnected parts come together, giving us the full picture of the puzzle so that we can work toward a solution.

Connecting the dots in neuroscience

Can research targeting one neurological disorder drive advancements for other diseases? Chris Henderson, Head of Research at Biogen, explains how experience in one disease can accelerate development of treatments for others.

Amyotrophic Lateral Sclerosis (ALS) at Biogen

We aspire to improve the lives of people living with and caring for those with ALS.

Biogen Digital Health

Biogen Digital Health aspires to transform patients’ lives and Biogen by making personalized & digital medicine in neuroscience a reality.

Healthy Climate, Healthy Lives™

Biogen marks one-year anniversary of $250 million, 20-year commitment to accelerate action on the greatest challenges of our time: climate, health and equity.

SOD1-ALS: Tofersen Early Access Program (EAP)
5/9/22 7:30 PM EDT
EISAI COMPLETES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE  UNDER THE ACCELERATED APPROVAL PATHWAY
View all news
Biogen updates delivered to your inbox
Diversity, Equity and Inclusion

Biogen is committed to the power of diversity – in our organization and among our patients and customers. Diversity is an essential asset of complementary strengths and perspectives from which all benefit, and which must unite us, not divide us.

Where Science Meets Humanity

Science that transforms patient lives. Science that seeks to solve societal problems. Science that acts with purpose. Science that is inspired by the diversity and passion of our people. Discover where science meets humanity at Biogen.

Follow us on social media